PXS 1.25% 7.9¢ pharmaxis ltd

News: PXS Pharmaxis Submits Investigational New Drug Application For Treatment Of Myelofibrosis

  1. 115,867 Posts.
    lightbulb Created with Sketch. 1383

    July 23 (Reuters) - Pharmaxis Ltd (PXS) :

    • PHARMAXIS LTD- SUBMITS INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR TREATMENT OF MYELOFIBROSIS
 
watchlist Created with Sketch. Add PXS (ASX) to my watchlist
(20min delay)
Last
7.9¢
Change
-0.001(1.25%)
Mkt cap ! $31.38M
Open High Low Value Volume
8.0¢ 8.0¢ 7.9¢ $13.76K 172.8K

Buyers (Bids)

No. Vol. Price($)
5 247034 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 109999 1
View Market Depth
Last trade - 15.28pm 05/03/2021 (20 minute delay) ?
(live)
Last
7.9¢
  Change
-0.001 ( 1.25 %)
Open High Low Volume
7.9¢ 7.9¢ 7.9¢ 4271
Last updated 14.07pm 05/03/2021 (live) ?
PXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.